Investors/Media

Investors / Media

Webcast ImageWebcast
Infinity Pharmaceuticals, Inc. at Cowen and Company 37th Annual Health Care Conference (Live)
03/06/17 at 4:00 p.m. ET
Infinity Pharmaceuticals, Inc. at Cowen and Company 37th Annual Health Care Conference
Monday, March 6, 2017 4:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Infinity Pharmaceuticals, Inc. is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways.

Stock Chart

More »
Stock chart for: INFI.O.  Currently trading at $2.45 with a 52 week high of $6.97 and a 52 week low of $0.84.

Recent Events

View all events »
Infinity Pharmaceuticals, Inc. at Cowen and Company 37th Annual Health Care Conference
Mar 06, 2017 4:00 p.m. ET
Infinity Pharmaceuticals, Inc. at 2017 BIO CEO & Investor Conference
Feb 13, 2017 3:00 p.m. ET
Infinity Pharmaceuticals, Inc. at 35th Annual J.P. Morgan Healthcare Conference
Jan 12, 2017 10:30 a.m. PT

Recent Releases

More >>
Infinity to Present at 37th Annual Cowen and Company Healthcare Conference
Feb 27, 2017
CAMBRIDGE, Mass., Feb. 27, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Cowen and Company 37th Annual Healthcare Conference on Monday, March 6, 2017, at 4:00 p.m. ET in Boston, MA. A live webcast of Infinity's presentation will be accessible on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event. About Infinity Infinity is an innovative biopharmaceutical company dedicated to a... 
Infinity Announces Promotion of Jeffery Kutok, M.D., Ph.D. to Chief Scientific Officer
Feb 13, 2017
CAMBRIDGE, Mass., Feb. 13, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that Jeffery Kutok, M.D., Ph.D. has been promoted to the role of chief scientific officer, effective immediately. In this role, Dr. Kutok will be responsible for overseeing biology and translational science efforts, including preclinical collaborations, to support the ongoing clinical development of IPI-549, Infinity's oral immuno-oncology development candidate that selectively inhibits ... 
Infinity to Present at the 2017 BIO CEO & Investor Conference
Feb 06, 2017
CAMBRIDGE, Mass., Feb. 6, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the 2017 BIO CEO & Investor Conference in New York City on Monday, February 13, 2017. During the conference, Joseph Pearlberg, M.D., Ph.D., vice president, clinical development at Infinity will participate in a panel at 11:00 a.m. ET entitled, "CAR-T, TILs, and Bispecifics: Immuno-Oncology Challenges and Opportunities." Additionally, Adelene Perkins, Infinity's chair and ... 
 

INFI (Common Stock)

Price:$2.45
Change: + 0.14 (6.06%)
Intraday High:$2.48
Intraday Low:$2.25
Volume:560,660
Feb 27, 2017 at 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Annual Report

2015 Annual Report
Data Provided by Thomson Reuters